title: Collaborative multidisciplinary workshop report: progress toward a Chlamydia pneumoniae vaccine.
authors.affiliation: Aventis Pasteur, Toronto, Ontario M2R 3T4, Canada. Andrew. Murdin@aventis.com
authors.forename: A D
authors.initials: AD
authors.lastname: Murdin
authors.forename: B
authors.initials: B
authors.lastname: Gellin
authors.forename: R C
authors.initials: RC
authors.lastname: Brunham
authors.forename: L A
authors.initials: LA
authors.lastname: Campbell
authors.forename: G
authors.initials: G
authors.lastname: Christiansen
authors.forename: C D
authors.initials: CD
authors.lastname: Deal
authors.forename: H B
authors.initials: HB
authors.lastname: Jenson
authors.forename: B
authors.initials: B
authors.lastname: Metcalf
authors.forename: B
authors.initials: B
authors.lastname: Sankaran
authors.forename: R S
authors.initials: RS
authors.lastname: Stephens
authors.forename: C
authors.initials: C
authors.lastname: Wilfert
mesh_terms: D000328:Adult; D000368:Aged; D000942:Antigens, Bacterial / Q000276:immunology; D001428:Bacterial Vaccines / Q000276:immunology*; D002648:Child; D002690:Chlamydia Infections / Q000517:prevention & control*; D016993:Chlamydophila pneumoniae / Q000276:immunology*; D006801:Humans
chemical_list: D000942:Antigens, Bacterial; D001428:Bacterial Vaccines